Nosa Med AB Cash Flow Conversion Efficiency
Nosa Med AB cash flow conversion efficiency. Based on the latest financial reports, Nosa Med AB (NOSA) has a cash flow conversion efficiency ratio of -0.043x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-1.78 Million ≈ $-191.34K USD) by net assets (Skr41.06 Million ≈ $4.42 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Nosa Med AB (2016–2025)
Cash flow conversion efficiency of Nosa Med AB from 2016 to 2025. This chart illustrates how Nosa Med AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Nosa Med AB (NOSA) share price today for real-time trading data and today's change.
Nosa Med AB Cash Flow Conversion Ratio Explained
Nosa Med AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Nosa Med AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nosa Med AB ranked by their cash flow conversion efficiency. Also see NOSA stock market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
QPR Software Oyj
HE:QPR1V
|
-0.282x |
|
Ancora Indonesia Resources Tbk
JK:OKAS
|
-0.027x |
|
Smart Logistics Global Limited Ordinary Shares
NASDAQ:SLGB
|
-0.051x |
|
Advanced Packaging Tech (Malaysia)
KLSE:9148
|
-0.030x |
|
Dycasa SA
BA:DYCA
|
-0.135x |
|
Blackwall Ltd
AU:BWF
|
-0.006x |
|
Sirona Biochem Corp
V:SBM
|
0.160x |
|
Thai Wire Products Public Company Limited
BK:TWP
|
-0.050x |
Annual Cash Flow Conversion Efficiency for Nosa Med AB (2016–2025)
The table below shows the annual cash flow conversion efficiency of Nosa Med AB from 2016 to 2025. Review Nosa Med AB (NOSA) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Skr41.06 Million ≈ $4.42 Million |
Skr-6.39 Million ≈ $-688.20K |
-0.156x | +74.29% |
| 2024-12-31 | Skr16.56 Million ≈ $1.78 Million |
Skr-10.03 Million ≈ $-1.08 Million |
-0.606x | +7.42% |
| 2023-12-31 | Skr26.75 Million ≈ $2.88 Million |
Skr-17.50 Million ≈ $-1.88 Million |
-0.654x | -73.15% |
| 2022-12-31 | Skr18.34 Million ≈ $1.97 Million |
Skr-6.93 Million ≈ $-745.46K |
-0.378x | -137.98% |
| 2021-12-31 | Skr39.10 Million ≈ $4.21 Million |
Skr-6.21 Million ≈ $-668.08K |
-0.159x | +76.94% |
| 2020-12-31 | Skr101.64 Million ≈ $10.94 Million |
Skr-69.96 Million ≈ $-7.53 Million |
-0.688x | -145.24% |
| 2019-12-31 | Skr187.85 Million ≈ $20.22 Million |
Skr-52.72 Million ≈ $-5.67 Million |
-0.281x | -60.30% |
| 2018-12-31 | Skr200.39 Million ≈ $21.56 Million |
Skr-35.09 Million ≈ $-3.78 Million |
-0.175x | -21.13% |
| 2017-12-31 | Skr192.22 Million ≈ $20.69 Million |
Skr-27.78 Million ≈ $-2.99 Million |
-0.145x | -3.44% |
| 2016-12-31 | Skr168.06 Million ≈ $18.09 Million |
Skr-23.48 Million ≈ $-2.53 Million |
-0.140x | -- |
About Nosa Med AB
Nosa Plugs AB, a medical technology company, develops, manufactures, and sells intranasal breathing products in Sweden, rest of Europe, the United States, Canada, and internationally. The company offers NOSA allergy filter that filters airborne allergens, such as pollen, pet dander, dust, and mold; NOSA smell training, a smell training medical device to improve the sense of smell for individuals … Read more